Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 5.4T | 5.5T | 5.4T | 5.4T |
| Cost of revenue | 4.2T | 4.4T | 4.2T | 4.2T |
| Gross profit | 1.1T | 1.2T | 1.1T | 1.2T |
| Operating expense | ||||
| Research & development | 353.3B | 267.7B | 262.7B | 215.9B |
| Selling general and admin | 711.2B | 514.8B | 629.3B | 495.8B |
| Other operating expenses | — | — | — | — |
| Operating income | 73.6B | 397.3B | 257.9B | 484.7B |
| Non operating interest income | ||||
| Income | 40.3B | 50.1B | 50.6B | 50.1B |
| Expense | 16.9B | 13.0B | 12.8B | 12.2B |
| Other income expense | -3.5B | -6.5B | -22.2B | 1.4B |
| Pretax income | 92.1B | 483.6B | 182.5B | 559.5B |
| Tax provision | 49.5B | 150.0B | 70.0B | 145.1B |
| Net income | 42.6B | 333.6B | 112.5B | 414.3B |
| Basic EPS | — | — | — | 245.4 |
| Diluted EPS | — | — | — | 245.4 |
| Basic average shares | — | — | — | 1.6B |
| Diluted average shares | — | — | — | 1.6B |
| EBITDA | 303.8B | 677.8B | 374.1B | 759.6B |
| Net income from continuing op. | 92.1B | 483.6B | 182.5B | 559.5B |
| Minority interests | -12.0B | -23B | -12.5B | -19.7B |
| Preferred stock dividends | — | — | — | — |